一致性
癌症
蛋白质组学
蛋白质组
前瞻性队列研究
血液蛋白质类
生物信息学
癌症生物标志物
生物
医学
肿瘤科
生物途径
计算生物学
内科学
生物标志物
疾病
队列
定量蛋白质组学
癌症预防
队列研究
癌细胞
癌症研究
病因学
荟萃分析
免疫学
生物标志物发现
癌症发病率
欧洲癌症与营养前瞻性调查
癌基因
乳腺癌
癌症筛查
作者
James W Yarmolinsky,Vivian Viallon,Vernon A. Burk,David C. Muller,Pieter Martijn Kolijn,Christina M. Lill,Konstantinos K. Tsilidis,Pietro Ferrari,George Richenberg,Ziqiao Wang,María Dolores Chirlaque López,Ana Jiménez-Zabala,Rosario Tumino,Carlotta Sacerdote,Nicholas J. Wareham,Zhe Huang,Karl Smith‐Byrne,Ruth C. Travis,Nilanjan Chatterjee,Elizabeth A. Platz
标识
DOI:10.64898/2026.09.22.26363676
摘要
< 0.05) across 25 cancer endpoints in multivariable-adjusted models, including 60 proteins associated with overall cancer risk. Confirmation analyses in the Atherosclerosis Risk in Communities (ARIC) Study cohort showed directional concordance for 78% of associations and statistical replication of 49% of findings. Most proteins were associated with a single cancer type, whereas 284 were associated with multiple cancers, indicating both shared and distinct biological pathways across cancer sites. Stratification by follow-up time revealed 523 protein associations that were restricted to specific time windows after blood collection (<2 years, <5 years, and >5 years), including 447 that were not apparent in primary analyses, highlighting proteins with potential roles as early detection or aetiological biomarkers. Proteins associated with cancer risk were enriched across diverse biological pathways and 315 corresponded to targets of approved cancer and non-cancer medications, while most proteins represent previously unrecognised links to cancer risk. As the most comprehensive prospective investigation of the plasma proteome and cancer risk to date, our study significantly expands our understanding of key biological pathways shaping cancer development and provides a resource for the scientific community to accelerate development of early detection strategies, biomarkers for risk stratification, and novel therapeutic interventions for cancer prevention.
科研通智能强力驱动
Strongly Powered by AbleSci AI